PFIZER4,092.00

Pfizer Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersGLAXOABBOTINDIAPOLYMEDONESOURCERAINBOWKIMSJUBLPHARMAVIJAYA
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations2,193.22,281.42,519.73,172.8
Other Income172.3232.8
Total Income2,373.72,453.62,707.63,405.6
Expenses
+ Cost of Materials Consumed335.8272.3309.5414.5
+ Purchases of Stock-in-Trade468.6512.8608.4791.3
+ Changes in Inventories-11.825.4-33.6-81.4
+ Employee Benefit Expense347.8371.3368.0450.1
+ Finance Costs15.48.49.510.9
+ Depreciation & Amortisation62.360.857.772.0
+ Other Expenses359.3446.7
Total Expenses1,635.61,610.31,682.82,104.1
EBITDA635.3740.2904.11,151.7
EBIT573.0679.4846.41,079.7
Profit
PBT before Exceptional Items738.1843.31,024.81,301.5
+ Exceptional Items-49.2
Pretax Income746.11,016.1975.71,252.4
+ Current Tax158.9264.1257.5328.5
+ Deferred Tax-3.0
Tax Expense325.5
Net Income551.3767.6722.4926.9
+ Net Income — Continuing Ops926.9
+ Other Comprehensive Income3.3
Total Comprehensive Income556.8768.3726.3930.2
Per Share
Basic EPS202.61
Diluted EPS119.38
Other Comprehensive Income — detail
+ Other Comprehensive Income3.3
+ Tax on Items NOT to be Reclassified0.4
+ Tax on Items to be Reclassified0.6
Per Share — as-filed variants
Basic EPS — Continuing Operations202.61
Diluted EPS — Continuing Operations119.38
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,400.61,470.91,635.32,048.4
Gross Margin %63.8664.4764.9064.56
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)738.1843.31,024.81,301.5
− Exceptional Items (reconciliation)-49.2
Net Income Adj (tax-effected)545.4638.0759.3963.3
EPS Adj210.56
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.00
Paid Up Equity Capital45.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.